Baxter Healthcare Corporation recalls Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcar
Recalled August 30, 2023 · FDA recall D-1103-2023 · Baxter Healthcare
Hazard
Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial. · FDA Class III
Units
13,502 vials
Sold at
Nationwide in the U.S.A.
Description
Labeling: Missing Label; customer complaint received that labels were partially or completely peeled off injection vial.
Product
Bendamustine HCl Injection, 100mg/4mL (25mg/mL), One 4 mL Multiple-Dose Vial, Rx only, Manufactured for Baxter Healthcare Corporation, Deerfield, IL 60015, NDC 10019-079-01.
Manufacturer(s)
Baxter Healthcare Corporation
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →